{"retracted":false,"update":{"timestamp":1394841600000,"doi":"10.1016/j.jneuroim.2014.01.001","type":"err"},"doi":"10.1016/j.jneuroim.2010.12.001","journal":"Journal of Neuroimmunology","publisher":"Elsevier BV","title":"Corrigendum to ‘Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression’ [Journal of Neuroimmunology, 233 (2011) 221–227]"}
